Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study
about
Interferon lambda: a new sword in cancer immunotherapyA variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virusHepatitis C virus protease inhibitor-resistance mutations: our experience and reviewGenetic background in nonalcoholic fatty liver disease: A comprehensive reviewThe 2015 Clinical Guidelines for the Diagnosis and Treatment of HIV/AIDS in HIV-Infected KoreansImpact of IL28B, ITPA and PNPLA3 genetic variants on therapeutic outcome and progression of hepatitis C virus infectionNatural history and clinical response: "it's the virus, stupid, or is it the host?"Regulation of hepatic innate immunity by hepatitis C virusNatural killer cell responses during viral infections: flexibility and conditioning of innate immunity by experienceHepatitis C virus adaptation to T-cell immune pressureSystematic review with meta-analysis: do interferon lambda 3 polymorphisms predict the outcome of interferon-therapy in hepatitis B infection?Influence of HIV and HCV on T cell antigen presentation and challenges in the development of vaccinesMiR-122 in hepatitis B virus and hepatitis C virus dual infectionPost-transcriptional regulation of interferons and their signaling pathwaysGenetic variants at the IFNL3 locus and their association with hepatitis C virus infections reveal novel insights into host-virus interactionsHepatitis C virus genotype 6: virology, epidemiology, genetic variation and clinical implicationTargeted induction of interferon-λ in humanized chimeric mouse liver abrogates hepatotropic virus infectionModeling host genetic regulation of influenza pathogenesis in the collaborative crossCopy number variation of genes involved in the hepatitis C virus-human interactomeInfluence of host resistance on viral adaptation: hepatitis C virus as a case studyFemale sex and IL28B, a synergism for spontaneous viral clearance in hepatitis C virus (HCV) seroconverters from a community-based cohortIdentification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohortA multicentre molecular analysis of hepatitis B and blood-borne virus coinfections in Viet NamRelation of IL28B gene polymorphism with biochemical and histological features in hepatitis C virus-induced liver diseaseAssociation of IFNL3 rs12979860 and rs8099917 with biochemical predictors of interferon responsiveness in chronic hepatitis C virus infectionHepatitis C virus infection among injection drug users with and without human immunodeficiency virus co-infectionInfluence of hepatitis C virus and IL28B genotypes on liver stiffnessWithin-host stochastic emergence dynamics of immune-escape mutantsRibavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort StudySystems immunogenetics of vaccinesHCV genotype-3a T cell immunity: specificity, function and impact of therapyImpact of IL28B-related single nucleotide polymorphisms on liver histopathology in chronic hepatitis C genotype 2 and 3An IL28B genotype-based clinical prediction model for treatment of chronic hepatitis CSerum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy.Pharmacogenetics of hepatitis C: transition from interferon-based therapies to direct-acting antiviral agentsGenome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts.Lack of evidence to support the association of a single IL28B genotype SNP rs12979860 with the HTLV-1 clinical outcomes and proviral load.Prioritizing genes responsible for host resistance to influenza using network approachesIL28B polymorphisms and clinical implications for hepatitis C virus infection in UzbekistanInterleukin28B and inosine triphosphatase help to personalize hepatitis C treatment.
P2860
Q21296797-51F20844-4FA6-4D9F-95B8-E38237CB430EQ24307721-6705759E-E8D1-45CE-BF1A-D0B41065AB60Q24628717-2117F592-FAA7-4297-B386-B7FE2553A500Q26780248-11D74A0F-4771-43E0-A106-44A401903034Q26781379-34FF842A-C15D-4001-89A9-C68A2D4E87EAQ26801381-2707D5D8-E660-4449-9D22-EA3ACEE55076Q26824094-48A0EC41-1158-4225-B54B-F37BA2ED07A4Q26824743-77AEB52D-0BCF-4FD1-B735-25C378EFA03FQ26850968-D7BE7C4C-1425-4DC9-B398-C1EAB1F7C59FQ26862729-737041FA-4409-458E-8929-9B9B888B3F81Q26865747-68A8997E-C829-4FC7-9B73-ABE00E81621FQ26999264-7DDB6E0C-4020-476A-B23B-E7CCE82C19E1Q27008894-F1768DD6-6744-4DEA-9EDD-B44E0ACC0FFFQ27014043-A60B0D9C-6AEC-4600-A247-F75960324869Q27014831-D70B2881-40BE-4CFE-AA70-6118CDDD01D7Q27024231-9AC4710B-CA2E-4AD1-9C19-F604E0428EC3Q27333253-FDC25BA4-1A40-4134-9A16-7598DE15073AQ27336134-F10C6839-5DE3-4557-9C4E-340AF442F3D9Q27468888-0D524A01-98C2-4969-99DD-0E1A8040D383Q28087595-8BCEFC30-900C-4FC3-9931-085757B045BDQ28477975-92640288-374C-4FFD-88C1-D9CB6C1270B1Q28478435-A34580F1-4564-4348-B30D-B4FA6974E4F7Q28480392-210C21FD-CCCE-4E85-9A68-C2122E4F0D7DQ28483964-B577CBA1-4B77-40C9-B7E1-B18C5BB4A067Q28534715-E216E54A-7F0E-4D8C-A06F-F7549A05A531Q28537754-D59F2513-4F32-43EF-AEA9-9FCFCD8623DDQ28542906-933B9BDD-CAC8-44E5-A6B4-8997C9239C53Q28544655-7DADF5B2-A462-42B2-A97E-43B00BFD094CQ28546829-94F91467-C93A-4C79-BC62-CA77157E05B1Q28661851-45F380A1-E3AF-4A51-99A0-7F970089A94BQ28687729-4CEE5EA4-9830-430C-8D5F-51ABEC3CF97EQ28732828-6C2C8CA9-93CB-4AA0-A4D8-6DA8056D4FE7Q28742764-0866FCBF-4F92-48B9-B311-E28B361EA128Q29417108-6325B770-3248-48B5-A90F-45A3228274E1Q30365599-D65558FF-57E2-4138-A90A-A8BF74E7F376Q30590832-9076F082-476D-4C78-8105-4392C9BE08D2Q31109635-63B3BAE3-E66F-43E0-9B80-6EB7161698E9Q31144248-319FB3FA-0425-459E-BAB1-5D0141ACC4DBQ31154491-1061507C-7189-43C1-871E-D22834F628E7Q33398664-0B0A67F6-E5A0-4E10-BA1C-7B2240B8DDBD
P2860
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Genetic variation in IL28B is ...... genome-wide association study
@ast
Genetic variation in IL28B is ...... genome-wide association study
@en
Genetic variation in IL28B is ...... genome-wide association study
@nl
type
label
Genetic variation in IL28B is ...... genome-wide association study
@ast
Genetic variation in IL28B is ...... genome-wide association study
@en
Genetic variation in IL28B is ...... genome-wide association study
@nl
prefLabel
Genetic variation in IL28B is ...... genome-wide association study
@ast
Genetic variation in IL28B is ...... genome-wide association study
@en
Genetic variation in IL28B is ...... genome-wide association study
@nl
P2093
P50
P921
P3181
P1433
P1476
Genetic variation in IL28B is ...... genome-wide association study
@en
P2093
Andrea Witteck
Andreas Cerny
Andri Rauch
Beat Müllhaupt
Francesco Negro
Jan Borovicka
Julia Di Iulio
Patrick Descombes
Raffaele Malinverni
Sara Colombo
P304
1338-45, 1345.e1-7
P3181
P356
10.1053/J.GASTRO.2009.12.056
P407
P50
P577
2010-04-01T00:00:00Z